Manage your subscriptions

Please tell us which emails you’d like to receive at  cdh3@hjmd.de.

 

Product Information
  Information about Spark Therapeutics, Inc.'s approved product.
Corporate News
  Updates and announcements from Spark Therapeutics, Inc. on our continuing efforts in gene therapy research.
Inherited Retinal Disease (IRD) Community
  Newsletters and updates from Spark Therapeutics, Inc.'s online resources for the IRD community.
Hemophilia Community
  Updates and stories from Spark Therapeutics, Inc.'s online resources for the hemophilia community.

If you’d like to unsubscribe from all future communications, please select the box below.

Remove Me From All Future Communications

Copyright © 2024 Spark Therapeutics, Inc.
N-ASV-US-420083-9